Microarray analyses of peripheral whole blood cells from ulcerative colitis patients: Effects of leukocytapheresis

International Journal of Molecular Medicine

Volumn 31, Issue 4, 2013, Pages 789-796

  Kobayashi, Teppei ^a   Mitsuyama, Keiichi ^a   Yamasaki, Hiroshi ^a   Masuda, Junya ^a   Takedatsu, Hidetoshi ^a   Kuwaki, Kotaro ^a   Yoshioka, Shinichiro ^a   Nagayama, Koji ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene expression; Leukocytapheresis; Microarray; Ulcerative colitis

Indexed keywords

CD74 ANTIGEN; CD97 ANTIGEN; GALECTIN 3; HAPTOGLOBIN; HLA DP ANTIGEN; HLA DRB1 ANTIGEN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGED; ARTICLE; BASOPHIL; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; NEUTROPHIL COUNT; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; ULCERATIVE COLITIS; UPREGULATION;

ADOLESCENT; ADULT; BLOOD CELL COUNT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; RNA, MESSENGER; UP-REGULATION;

EID: 84875253904     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1270     Document Type: Article

References (54)

1. Podolsky DK: Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
2. Bamias G, Nyce MR, De La Rue SA, Cominelli F; American College of Physicians; American Physiological Society: New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med 143: 895-904, 2005.
3. Targan SR and Karp LC: Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 206: 296-305, 2005.
4. Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P and Doe WF: Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol 10: 387-395, 1995.
5. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O and Scott H: Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 35: 669-674, 1994.
6. Kondoh T, Hidaka Y, Katoh H, Inoue N and Saito S: Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. Artif Organs 15: 180-188, 1991.
7. Sawada K, Ohnishi K, Fukui S, et al: Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 30: 322-329, 1995.
8. Ortolano GA, Capetandes A and Wenz B: A review of leukofiltration therapy for decreasing the morbidity associated with cardiopulmonary bypass and acute inflammatory bowel disease. Ther Apher 6: 119-129, 2002.
9. Sawada K, Muto T, Shimoyama T, et al: Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 9: 307-321, 2003.
10. Yajima T, Takaishi H, Kanai T, et al: Predictive factors of response to leukocytapheresis therapy for ulcerative colitis. Ther Apher 2: 115-119, 1998.
11. Sasaki M, Tsujikawa T, Fujiyama Y and Bamba T: Leuko-cytapheresis therapy for severe ulcerative colitis. Ther Apher 2: 101-104, 1998.
12. Kosaka T, Sawada K, Ohnishi K, et al: Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease. Intern Med 38: 102-111, 1999.
13. Hidaka T, Suzuki K, Matsuki Y, et al: Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 42: 431-437, 1999.
14. Ueki Y, Yamasaki S, Kanamoto Y, et al: Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology 39: 165-171, 2000.
15. Furuta T, Hotta O, Yusa N, Horigome I, Chiba S and Taguma Y: Lymphocytapheresis to treat rapidly progressive glomerulonephritis: a randomised comparison with steroid-pulse treatment. Lancet 352: 203-204, 1998.
16. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE and Harrington CA: Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 4: 1-11, 2000.
17. Lawrance IC, Fiocchi C and Chakravarti S: Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10: 445-456, 2001.
18. Heller RA, Schena M, Chai A, et al: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94: 2150-2155, 1997.
19. Truelove SC and Witts LJ: Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 2: 1041-1048, 1955.
20. Nagase K, Sawada K, Ohnishi K, Egashira A, Ohkusu K and Shimoyama T: Complications of leukocytapheresis. Ther Apher 2: 120-124, 1998.
21. Hashimoto S, Suzuki T, Dong HY, Yamazaki N and Matsushima K: Serial analysis of gene expression in human monocytes and macrophages. Blood 94: 837-844, 1999.
22. Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N and Matsushima K: Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 94: 845-852, 1999.
23. Hashimoto SI, Suzuki T, Nagai S, Yamashita T, Toyoda N and Matsushima K: Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 96: 2206-2214, 2000.
24. Nagai S, Hashimoto S, Yamashita T, et al: Comprehensive gene expression profile of human activated T(h)1- and T(h)2-polarized cells. Int Immunol 13: 367-376, 2001.
25. Khodursky AB, Peter BJ, Cozzarelli NR, Botstein D, Brown PO and Yanofsky C: DNA microarray analysis of gene expression in response to physiological and genetic changes that affect tryptophan metabolism in Escherichia coli. Proc Natl Acad Sci USA 97: 12170-12175, 2000.
26. Yang YH, Dudoit S, Luu P, et al: Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30: e15, 2002.
27. Baechler EC, Batliwalla FM, Karypis G, et al: Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun 5: 347-353, 2004.
28. Rauschmayr T, Groves RW and Kupper TS: Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. Proc Natl Acad Sci USA 94: 5814-5819, 1997.
29. Odink K, Cerletti N, Bruggen J, et al: Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80-82, 1987.
30. Cui XF, Li HH, Goradia TM, et al: Single-sperm typing: determination of genetic distance between the G gamma-globin and parathyroid hormone loci by using the polymerase chain reaction and allele-specific oligomers. Proc Natl Acad Sci USA 86: 9389-9393, 1989.
31. Robertson MW, Albrandt K, Keller D and Liu FT: Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms. Biochemistry 29: 8093-8100, 1990.
32. Takahashi N, Ueda S, Obata M, Nikaido T, Nakai S and Honjo T: Structure of human immunoglobulin gamma genes: implications for evolution of a gene family. Cell 29: 671-679, 1982.
33. Mitsuyama K, Suzuki A, Matsumoto S, et al: Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis. Clin Exp Immunol 141: 130-140, 2005.
34. Andoh A, Ogawa A, Kitamura K, et al: Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J Gastroenterol 39: 1150-1157, 2004.
35. Noguchi M, Hiwatashi N, Hayakawa T and Toyota T: Leukocyte removal filter-passed lymphocytes produce large amounts of interleukin-4 in immunotherapy for inflammatory bowel disease: role of bystander suppression. Ther Apher 2: 109-114, 1998.
36. Gray JX, Haino M, Roth MJ, et al: CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol 157: 5438-5447, 1996.
37. Leemans JC, te Velde AA, Florquin S, et al: The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J Immunol 172: 1125-1131, 2004.
38. Leng L, Metz CN, Fang Y, et al: MIF signal transduction initiated by binding to CD74. J Exp Med 197: 1467-1476, 2003.
39. Ohkawara T, Nishihira J, Takeda H, et al: Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 123: 256-270, 2002.
40. Salomon P, Pizzimenti A, Panja A, Reisman A and Mayer L: The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium. Autoimmunity 9: 141-149, 1991.
41. Kjeldsen L, Johnsen AH, Sengelov H and Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268: 10425-10432, 1993.
42. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M and Kjeldsen L: Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38: 414-420, 1996.
43. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS and Kleinman HK: Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 91: 977-985, 1993.
44. Laine E, Couderc R, Roch-Arveiller M, Vasson MP, Giroud JP and Raichvarg D: Modulation of human polymorphonuclear neutrophil functions by alpha 1-acid glycoprotein. Inflammation 14: 1-9, 1990.
45. Wispe JR, Clark JC, Burhans MS, Kropp KE, Korfhagen TR and Whitsett JA: Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim Biophys Acta 994: 30-36, 1989.
46. Russell L and Forsdyke DR: A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol 10: 581-591, 1991.
47. Warburton G, Nares S, Angelov N, Brahim JS, Dionne RA and Wahl SM: Transcriptional events in a clinical model of oral mucosal tissue injury and repair. Wound Repair Regen 13: 19-26, 2005.
48. Pirila E, Ramamurthy NS, Sorsa T, Salo T, Hietanen J and Maisi P: Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma2-chain expression in murine inflammatory bowel disease (ulcerative colitis). Dig Dis Sci 48: 93-98, 2003.
49. Yamaji K, Yang K, Tsuda H and Hashimoto H: Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers. Ther Apher 6: 402-412, 2002.
50. Sawada K, Ohnishi K, Kosaka T, et al: Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apher 1: 207-211, 1997.
51. Danese S: New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 61: 918-932, 2012.
52. Rutgeerts P, Vermeire S and Van Assche G: Biological therapies for inflammatory bowel diseases. Gastroenterology 136: 1182-1197, 2009.
53. Mitsuyama K and Sata M: Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Expert Opin Ther Targets 12: 301-312, 2008.
54. Duijvestein M, van den Brink GR and Hommes DW: Stem cells as potential novel therapeutic strategy for inflammatory bowel disease. J Crohns Colitis 2: 99-106, 2008.